Genpact LTD is 2.0x more valuable than EXPONENT INC by market capitalization ($5.46 B vs $2.69 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | EXPO | G |
|---|---|---|
| Market cap | $2.69 B | $5.46 B |
| US-listed rank | #1894 | #1323 |
| Revenue (latest FY) | $582.01M | $5.08B |
| Net income (latest FY) | $106.01M | $552.49M |
| Net margin | 18.2% | 10.9% |
| P/E (trailing FY) | 25.3 | 9.9 |
| SEC filings | 2,029 | 1,502 |
Genpact LTD is 2.0x more valuable than EXPONENT INC by market capitalization ($5.46 B vs $2.69 B).
In their latest fiscal years, EXPONENT INC reported $582.01M in revenue while Genpact LTD reported $5.08B.
Full pages: EXPONENT INC and Genpact LTD, or browse the full rankings.